POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 110 filers reported holding POINT BIOPHARMA GLOBAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,482,913 | -24.5% | 822,026 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $7,258,818 | +32.0% | 801,194 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $5,497,981 | +4.1% | 756,256 | +4.4% | 0.00% | 0.0% |
| Q4 2022 | $5,280,227 | +6.3% | 724,311 | +12.7% | 0.00% | 0.0% |
| Q3 2022 | $4,969,000 | +13.2% | 642,809 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $4,391,000 | +302.5% | 644,823 | +371.1% | 0.00% | – |
| Q1 2022 | $1,091,000 | +39.9% | 136,882 | -1.7% | 0.00% | – |
| Q4 2021 | $780,000 | -21.9% | 139,318 | +7.3% | 0.00% | – |
| Q3 2021 | $999,000 | – | 129,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,420,501 | $16,484,000 | 3.95% |
| Fairmount Funds Management LLC | 1,833,950 | $12,489,000 | 2.86% |
| JOHNSON & JOHNSON | 1,000,000 | $6,810,000 | 1.74% |
| RA Capital Management | 9,003,018 | $61,311,000 | 1.64% |
| Sio Capital Management, LLC | 504,545 | $3,436,000 | 1.29% |
| BVF INC/IL | 3,367,826 | $22,935,000 | 1.11% |
| Boxer Capital, LLC | 2,500,000 | $17,025,000 | 1.08% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $20,528,000 | 0.78% |
| ORACLE INVESTMENT MANAGEMENT INC | 129,810 | $884,000 | 0.27% |
| Perceptive Advisors | 1,073,995 | $7,314,000 | 0.23% |